The association of annexin A2 and cancers

Clinical and Translational Oncology

Volumn 14, Issue 9, 2012, Pages 634-640

  Zhang, Xiaohui ^a   Liu, Shuqing ^a   Guo, Chunmei ^a   Zong, Junwei ^a   Sun, Ming Zhong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Annexin A2; Cancer; Development; Invasion; Metastasis

Indexed keywords

ARSENIC TRIOXIDE; DOXORUBICIN; LIPOCORTIN 2; RETINOIC ACID;

ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CYTOPLASM; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; ENDOTHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MACROPHAGE; METASTASIS; MONONUCLEAR CELL; NASOPHARYNX CARCINOMA; NEOPLASM; NOSE CARCINOMA; PANCREAS CANCER; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINONASAL ADENOCARCINOMA; TUMOR CELL; UPREGULATION;

ANNEXIN A2; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; NEOPLASMS; UP-REGULATION;

EID: 84871254088     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0855-6     Document Type: Article

References (50)

1. Moss SE (2004) The annexins. Genome Biol 5:219
2. Radke K, Martin GS (1979) Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypep-tides. Proc Natl Acad Sci USA 76:5212-5216
3. Sarafian T, Pradel LA, Henry JP et al (1991) The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J Cell Biol 114:1135-1147
4. Chiang Y, Rizzino A, Sibenaller ZA et al (1999) Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 199:139-147
5. Mussunoor S, Murray GI (2008) The role of annexins in tumour development and progression. J Pathol 216:131-140
6. Vermeersch H, Loose D, Lahorte C et al (2004) 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma. Nucl Med Commun 25:259-263
7. Liu J, Rothermund CA, Ayala-Sanmartin J et al (2003) Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC Biochem 4:10
8. Jost M, Gerke V (1996) Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim Biophys Acta 1313:283-289
9. Flood EC, Hajjar KA (2011) The annexin A2 system and vascular homeostasis. Vasc Pharmacol 54:59-67
10. Yang LP, Yang ZL, Tan XG et al (2010) Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder. Zhonghua Zhong Liu Za Zhi 32:595-599
11. Fan X, Yu Z, Liu J et al (2010) Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke 41:S54-S58
12. Chiang Y (1993) Cycle annexin II expression is regulated during mammalian cell. Cancer Res 53:6017
13. Singh P (2007) Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 252:19-35
14. Zheng L, Foley K, Huang L et al (2011) Tyrosine 23 phosphorylation- dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 6:e19390
15. Emoto K, Yamada Y, Sawada H et al (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92:1419-1426
16. Katayama M, Nakano H, Ishiuchi A et al (2006) Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel elec-trophoresis and mass spectrometry. Surg Today 36:1085-1093
17. Ji NY, Park MY, Kang YH et al (2009) Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med 24:765-771
18. Kittaka N, Takemasa I, Takeda Y et al (2008) Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur J Cancer 44:885-897
19. Yu GR, Kim SH, Park SH et al (2007) Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma. Exp Mol Med 39:641-652
20. Mohammad HS, Kurokohchi K, Yoneyama H et al (2008) Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 33:1157-1163
21. Zhao P, Zhang W, Tang J et al (2010) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101:387-395
22. Zhao P, Zhang W, Wang SJ et al (2011) HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology 54:2012-2024
23. Sharma MR, Koltowski L, Ownbey RT et al (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81:146-156
24. Chuthapisith S, Layfield R, Kerr ID et al (2007) Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol 30:1545-1551
25. Zhang F, Zhang L, Zhang B et al (2009) Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res 8:5041-5047
26. Sharma M, Ownbey RT, Sharma MC (2010) Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 88:278-286
27. Kim J, Hajjar KA (2002) Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 7:d341-d348
28. Dassah M, Deora AB, He K et al (2009) The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys 28 (Spec):F20-F28
29. Ling Q, Jacovina AT, Deora A et al (2004) Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113:38-48
30. Liu Y, Wang Z, Jiang M et al (2011) The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res 35:879-884
31. Zhang XH, Hu Y, Bao L et al (2009) Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute mye-logenous leukemia. Chin Med J 122:1969-1973
32. Domoto T (2006) Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 98:77-82
33. Ohno Y, Izumi M, Kawamura T et al (2009) Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 101:287-294
34. Tian R, Wei LM, Qin RY et al (2008) Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins. Dig Dis Sci 53:65-72
35. Chung CY, Erickson HP (1994) Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126:539-548
36. Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Bio Cell 7:883-892
37. Esposito I, Penzel R, Chaib-Harrireche M et al (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208:673-685
38. Lehnigk U, Zimmermann U, Woenckhaus C et al (2005) Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients. Histol Histopath 20:673-680
39. Stewart J, Fleshner N, Cole H et al (2007) Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. J Clin Pathol 60:773-780
40. Yee DS, Narula N, Ramzy I et al (2007) Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Arch Pathol Lab Med 131:902-908
41. Chetcuti A, Margan SH, Russell P et al (2001) Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 61:6331-6334
42. Liu JW, Shen JJ, Tanzillo-Swarts A et al (2003) Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22:1475-1485
43. Ellinger J, Bastian PJ, Jurgan T et al (2008) CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 71:161-167
44. Dong Q, Patel M, Scott KF et al (2006) Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett 240:9-16
45. Shiozawa Y, Havens AM, Jung Y et al (2008) Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105:370-380
46. Qi YJ, Wang LD, Jiao XY et al (2007) Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province. Ai Zheng 26:730-736
47. Chan CML (2008) Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and 2-tubulin for nasopharyngeal carcinoma. Arch Pathol Lab Med 132:675-683
48. Rodrigo JP, Garcia-Pedrero JM, Llorente JL et al (2011) Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarci-nomas. Hum Pathol 42:88-94
49. Tapia JPR (2007) Annexin A2 Expression in Head and Neck Squamous Cell Carcinoma. Acta Otorrinolaringol Esp 58:257-262
50. Pena-Alonso E, Rodrigo JP, Parra IC et al (2008) Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett 263:89-98